301 filings
DEF 14A
OCX
Oncocyte Corporation
Definitive proxy
29 Apr 24
5:23pm
D
OCX
Oncocyte Corporation
24 Apr 24
$15.81 mm in equity / options / securities to be acquired, sold $15.81 mm, 21 investors
6:50pm
10-K
2023 FY
OCX
Oncocyte Corporation
Annual report
15 Apr 24
9:55pm
8-K
OCX
Oncocyte Corporation
12 Apr 24
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
6:04am
8-K
OCX
Oncocyte Corporation
11 Apr 24
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
5:28pm
NT 10-K
dkflpc nj4n
1 Apr 24
Notice of late annual filing
5:05pm
8-K
vxyn w2qdtfad3
23 Jan 24
Regulation FD Disclosure
4:39pm
8-K
atnrs9vy
9 Nov 23
Oncocyte Reports Third Quarter 2023 Financial Results
7:05am
8-K/A
gcku opt2
10 Oct 23
Changes in Registrant's Certifying Accountant
4:48pm
8-K
pbv0 w9ly
5 Oct 23
Changes in Registrant's Certifying Accountant
4:05pm
8-K
07s542twk
20 Sep 23
Entry into a Material Definitive Agreement
9:00am
8-K
0ez z70tlk1kian
28 Aug 23
Other Events
4:05pm
8-K
uxo326m7x beljmflh
10 Aug 23
Oncocyte Reports Second Quarter 2023 Financial Results
7:05am
8-K
1ox4ay x63mm79
24 Jul 23
ONCOCYTE ANNOUNCES 1-for-20 reverse stock split
5:28pm
DEFA14A
tuk1x oc16m
21 Jul 23
Additional proxy soliciting materials
5:16pm
8-K
iqo5pwjlmtec
14 Jul 23
Departure of Directors or Certain Officers
6:03am